-+ 0.00%
-+ 0.00%
-+ 0.00%

Eupraxia presents RESOLVE trial data at Digestive Disease Week annual meeting

PUBT·04/22/2026 11:04:21
Listen to the news
Eupraxia presents RESOLVE trial data at Digestive Disease Week annual meeting
  • Eupraxia Pharmaceuticals will present Phase 1b/2 RESOLVE trial data on EP-104GI at Digestive Disease Week in Chicago on May 2-5, 2026.
  • An oral presentation is scheduled for May 3, 2026.
  • Three poster presentations are slated for May 5, 2026.
  • Eupraxia will host a virtual investor event on May 4, 2026 at 7 a.m. CT.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eupraxia Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604220700PRIMZONECNPR____9694277) on April 22, 2026, and is solely responsible for the information contained therein.